This is in accordance with previous studies showing that increased tau acetylation at Lys174 or Lys280 could promote tau accumulation and aggravate tau-mediated neurodegeneration and cognitive impairments [16,17]. The gene discussed is MAPT; the disease is Cognitive impairment.